eClinical Solutions has introduced enhancements and AI-powered functionalities to its Elluminate Clinical Data Cloud platform. These updates aim to streamline clinical trial oversight and reduce manual workload, ensuring data integrity and patient safety.

eClinical Solutions has added the Protocol Deviations feature, which improves trial oversight. It allows users to standardize and manage protocol deviation data within the Elluminate platform, simplifying deviation record management and ensuring compliance with the Protocol Deviation Assessment Plan (PDAP).

The platform has also incorporated AI capabilities, including:

•Audit Trail Review: Utilizes machine learning to detect anomalies in data changes and deletions, enhancing oversight.
•Data Classification: Streamlining data processing by using machine learning and natural language processing to classify incoming data based on common industry standards (CDASH and SDTM).

These enhancements provide clinical teams with the following benefits:

• Improved oversight and protocol compliance
• Reduced manual workload and increased efficiency
• Enhanced data integrity and patient safety
• Risk-based approaches for boosting operational efficiency

eClinical Solutions CEO Raj Indupuri emphasizes that successful clinical trials depend on rigorous protocols and efficient protocol deviation management. The enhancements in elluminate support these requirements, enabling life sciences organizations to reduce risks and accelerate trials.

For further information on the Elluminate Clinical Data Cloud and its comprehensive data products, visit the eClinical Solutions website at www.eclinicalsol.com/platform.

Source link: http://www.businesswire.com/news/home/20240806635634/en/eClinical-Solutions-Introduces-Protocol-Deviations-Among-New-Product-Innovations-Boosting-Operational-Success-for-Clinical-Trials

+ posts

Jon Napitupulu is Director of Media Relations at The Clinical Trial Vanguard. Jon, a computer data scientist, focuses on the latest clinical trial industry news and trends.